Four Chinese Firms Snag Global First-In-Class Approvals In China

 
• By Dexter Jie Yan
  
first line treatment
Four Chinese drugs have recently become first movers in their respective classes globally. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from China